By James P. Steinberg, MD, and Jesse T. Jacob, MD
A hospital epidemiology perspective on what we’ve discovered from the infection prevention response to COVID-19 Looking at some of the lessons learned from the response to the early phases of the COVID-19 pandemic from the perspective of the hospital epidemiologist, we can improve preparedness for future events by understanding how our hospitals used contemporary knowledge and ... Continue Reading
By Alexis P. Calloway, M.D
Much focus is given to the long- and short-term impact of commonly tested sexually transmitted infections such as HIV, chlamydia, gonorrhea and HPV on reproductive health. As the medical landscape of diagnosis and therapeutic options for infertility evolve, it is just as important to focus on viral hepatitis as well, with particular emphasis on Hepatitis B and C. Viral ... Continue Reading
By Sandra Adams Fryhofer M.D., MACP, FRCP On Feb 1, 2016, President Obama announced “Moonshot,” a new billion-dollar national initiative “to eliminate cancer as we know it.” In his announcement, the President predicted 1.6 million new cancer cases and 600,000 deaths in the United States in 2016. He discussed recent advances in cancer treatment, including using immunotherapy ... Continue Reading
By Amanda Feldpausch, MPH; Julie Gabel, DVM, MPH; and Cherie L. Drenzek, DVM, MS The Zika virus is a mosquito-borne flavivirus primarily transmitted to humans by Aedes aegypti mosquitoes, but it can also be transmitted sexually, intrauterine (resulting in congenital infection), intrapartum, via blood transfusion and by laboratory exposure. Zika virus outbreaks ... Continue Reading
By Vincent C. Marconi, M.D., and Mirko Paiardini, Ph.D. For the first time in almost three decades of AIDS research, the international scientific community has undertaken a large-scale, concerted effort to discover a cure for HIV. Several anecdotal reports and small clinical studies have provided some optimistic insights into the feasibility of HIV eradication. In 2009, ... Continue Reading
By Andres F. Camacho-Gonzalez, M.D., and Sophia A. Hussen, M.D. At a time when HIV rates are stabilizing in most population sub-groups, the prevalence of HIV in youth is steadily increasing in the United States. This trend is explained in part by increased survival of perinatally infected youth, but it is primarily attributable to increases in incident infections during ... Continue Reading
Morehouse School of Medicine, in partnership with The White House Office of Public Engagement & Office of National AIDS Policy, recently hosted the fourth White House Conference on HIV/AIDS at Morehouse School of Medicine’s Louis W. Sullivan National Center for Primary Care. The White House Conference on HIV/AIDS offers advocates, community leaders and members of the ... Continue Reading
A five-year, multi-site international study has shown that human papillomavirus (HPV) vaccinations given to adolescents and young women decrease the number of abnormal Pap smears, biopsies and cases of genital warts. Since some of these genital abnormalities are identified as precursors to cancer, it is anticipated that these findings will eventually translate into lower ... Continue Reading
September 2008 Georgia is one of 22 states that participated in the first collection of HIV-incidence data as part of the Centers for Disease Control and Prevention's (CDC) new national HIV-incidence surveillance system. The new system estimates that 56,300 individuals nationwide became newly infected with HIV in 2006 - a 40% increase from the previous annual estimate of ... Continue Reading
